Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 2.73% | $1.53B | ― | ― | ― | |
| ASML Holding NV | 1.63% | $912.51M | €347.07B | 30.57% | 76 Outperform | |
| Roche Holding AG | 1.07% | $601.68M | CHF256.01B | 38.07% | 73 Outperform | |
| AstraZeneca | 1.03% | $577.07M | £209.38B | 28.56% | 80 Outperform | |
| HSBC Holdings | 0.99% | $554.41M | HK$1.99T | 46.73% | 80 Outperform | |
| SAP SE | 0.95% | $536.13M | €241.18B | -14.07% | 66 Neutral | |
| Novartis AG | 0.95% | $533.39M | CHF204.56B | 21.14% | 80 Outperform | |
| Nestlé SA | 0.95% | $531.70M | CHF198.25B | 17.61% | 71 Outperform | |
| Royal Bank Of Canada | 0.89% | $502.18M | $232.81B | 34.49% | 75 Outperform | |
| Toyota Motor | 0.86% | $484.95M | ¥43.40T | 25.16% | 80 Outperform |